Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
about
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.Severe therapy resistant asthma in children: translational approaches to uncover sub-phenotypes.
P2860
Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mepolizumab in the management ...... ence and practical experience.
@ast
Mepolizumab in the management ...... ence and practical experience.
@en
Mepolizumab in the management ...... ence and practical experience.
@nl
type
label
Mepolizumab in the management ...... ence and practical experience.
@ast
Mepolizumab in the management ...... ence and practical experience.
@en
Mepolizumab in the management ...... ence and practical experience.
@nl
prefLabel
Mepolizumab in the management ...... ence and practical experience.
@ast
Mepolizumab in the management ...... ence and practical experience.
@en
Mepolizumab in the management ...... ence and practical experience.
@nl
P2860
P50
P921
P356
P1476
Mepolizumab in the management ...... ence and practical experience.
@en
P2093
Gilda Varricchi
P2860
P356
10.1177/1753465816673303
P577
2016-11-17T00:00:00Z
2017-01-01T00:00:00Z